febuxostat has been researched along with Cardiac Failure in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, T; Kobayashi, A; Konno, I; Kunii, H; Machii, H; Miyamoto, T; Nakazato, K; Niizeki, T; Nozaki, N; Suzuki, S; Takeishi, Y; Tsuda, A; Tsuda, T; Yamaguchi, O; Yamaki, T; Yokokawa, T; Yoshihisa, A | 1 |
| Afsar, B; Cherney, D; Covic, A; Dincer, N; Erden, N; Kanbay, M; Kuwabara, M; Ortiz, A; Rossignol, P; Sag, AA; Siriopol, D; Yilmaz, O | 1 |
| Gu, J; Lin, H; Pan, JA; Wang, CQ; Zhang, JF | 1 |
| Fukushima, A; Kinugawa, S; Murohara, T; Okumura, T; Tsutsui, H; Yokota, T | 1 |
| Borghi, C; Cicero, AFG; Cosentino, ER; Degli Esposti, D; Kuwabara, M | 1 |
| Citoni, B; Presta, V; Tocci, G | 1 |
| Kang, EH; Kim, SC | 1 |
| Gao, LG; Hui, RT; Luo, F; Wen, D; Yao, XP; Zhang, L; Zhou, XL | 1 |
| Alonso-Pacho, A; de la Puerta González-Quevedo, C; Fabregate-Fuente, M; Sabán-Ruiz, J | 1 |
| Hamlin, RL; Kijtawornrat, A; Lolly, JL; Roche, BM; Shemanski, D; Wessale, JL; Zhao, L | 1 |
4 review(s) available for febuxostat and Cardiac Failure
| Article | Year |
|---|---|
Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Heart Failure; Humans; Oxypurinol; Uric Acid; Xanthine Oxidase | 2020 |
Cardiovascular Safety of Urate Lowering Therapies.
Topics: Allopurinol; Cardiovascular Diseases; Endothelium; Febuxostat; Gout; Gout Suppressants; Heart Failure; Humans; Hypertension; Hyperuricemia; Myocardial Infarction; Probenecid; Risk; Stroke; Uricosuric Agents; Xanthine Oxidase | 2019 |
Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure?
Topics: Animals; Chronic Disease; Febuxostat; Heart Failure; Humans; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2010 |
Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Febuxostat; Heart Failure; Humans; Inflammation; Ischemia; Rabbits; Rats; Renal Insufficiency, Chronic; Thiazoles; Treatment Outcome; Xanthine Oxidase | 2013 |
2 trial(s) available for febuxostat and Cardiac Failure
| Article | Year |
|---|---|
Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial.
Topics: Allopurinol; Febuxostat; Heart Failure; Humans; Hyperuricemia; Uric Acid | 2021 |
Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Febuxostat; Female; Gout Suppressants; Heart Failure; Hospitalization; Humans; Hyperuricemia; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Fragments; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2018 |
4 other study(ies) available for febuxostat and Cardiac Failure
| Article | Year |
|---|---|
Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
Topics: Aged; Asymptomatic Diseases; Biomarkers; Blood Pressure; Databases, Factual; Diastole; Disease Progression; Drug Prescriptions; Febuxostat; Female; Gout Suppressants; Heart Disease Risk Factors; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Male; Middle Aged; Protective Factors; Retrospective Studies; Risk Assessment; Stroke Volume; Time Factors; Uric Acid; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients.
Topics: Aged; Aged, 80 and over; Allopurinol; Febuxostat; Female; Gout Suppressants; Heart Failure; Humans; Hyperuricemia; Male; Middle Aged | 2019 |
Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?
Topics: Aged; Allopurinol; Enzyme Inhibitors; Febuxostat; Heart Failure; Humans; Xanthine Oxidase | 2019 |
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Topics: Allopurinol; Animals; Body Weight; Echocardiography; Enzyme Inhibitors; Febuxostat; Heart Failure; Male; Myocardial Infarction; Myocardium; Organ Size; Rabbits; Thiazoles; Time Factors; Xanthine Oxidase | 2008 |